Evista, New Breast Cancer Treatment

Written by

Mon, September 17, 2007

Additional Posts

Isn't it ironic? Just a couple of years after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug, manufacturer Eli Lilly has finally gained FDA approval for the use of the popular osteoporosis drug for prevention of breast cancer in postmenopausal women. Evis...

Read the rest of this post >>

Hide Comments | Add comment

Notify me when there are new comments

laura

9/20/07 6:43am

how interesting--have been taking it for years for bones and breasts. so far so good. it would be nice, however, that when something as postive as this comes along, rather than the long winded negatives, just give us a little bit of hope. it's a scary world out there, and all we have are nay sayers who are afraid of being sued if we do what's necessary to stay ahead of the curve. nothing is perfect, and we all know that--so stop telling us bad--just give us some good. for all the money we spend on reseach we deserve it!!

Lila de Tantillo

9/22/07 8:22pm

Thanks so much for your response! Of course you're right, it's always best to focus on the good news. But with any medication we have to be aware of the risks too to make the best decision possible.

Debra Jarvis

2/16/08 12:23pm

I begged my oncologist to switch me to Evista because I didn't like how I felt on Tamoxifen AND I have significant osteoporosis. The Evista has slightly helped my osteoporosis. But she is bugging me to go back on Tamoxifen because she says Evista prevents breast cancer in women who have never had it, but it doesn't prevent a recurrence.

What do you know about that?

Evista, New Breast Cancer Treatment

Additional Posts

Ask a Question